Saint-Gobain’s Performance Plastics Life Sciences business has acquired the pharmaceutical business of Micro Hydraulics, Ltd., a Dublin, Ireland, based supplier and manufacturer of single-use components and systems for the pharmaceutical and biopharmaceutical industries.
Micro Hydraulics was founded in 1982 to supply hydraulic, industrial and fluid handling components into the Irish market. To better service the emerging local market needs, in 2005 Micro created its Pharma division to focus on the expanding Irish pharmaceutical industry. Today, Micro Hydraulics is one of the region’s leading providers of single-use fluid handling solutions for high purity applications in pharmaceutical and bioprocessing industries. The hydraulic and industrial divisions of the business are not affected by the transaction.
“The acquisition of the Micro Hydraulics Pharma business is a continuation of our long term strategy to expand our service and product offerings while increasing our localized presence for our customers,” says Steve Maddox, General Manager of the Saint-Gobain Life Sciences business. “We’re excited to preserve and build upon the exceptional service model that the Micro team has created, while leveraging our World Class Manufacturing and Quality Systems to bring an enhanced value offering to our customers in the region.”
The Saint-Gobain Life Sciences business has been providing fluid handling solutions to the healthcare industry for more than 45 years. Today, Saint-Gobain Life Science operates out of 19 manufacturing locations worldwide, and is recognized as a world-wide leader in material science based products and capabilities used in patient well-being through medical devices, drug development, pharmaceutical and biopharmaceutical processing, and cell and gene therapies. To learn more about Saint-Gobain’s solutions, visit www.lifesciences.saint-gobain.com.